2,094
Views
6
CrossRef citations to date
0
Altmetric
Article; Medical Biotechnology

Glycemic control in type 1 diabetes mellitus among Bulgarian children and adolescents: the results from the first and the second national examination of HbA1c

, , , , , , , , , & show all
Pages 1198-1203 | Received 12 Mar 2017, Accepted 11 Sep 2017, Published online: 15 Sep 2017

References

  • Soltesz G, Patterson CC, Dahlquist G, et al. Worldwide childhood type 1 diabetes incidence – what can we learn from epidemiology ? Pediatr Diabetes. 2007;8(Suppl. 6):6–14.
  • Maahs DM, West NA, Lawrence JM, et al. Chapter 1: epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39(3):481–497.
  • Patterson CC, Dahlquist GG, Gyürüs E, et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: A multicenter prospective registration study. Lancet. 2009;373:2027–2033.
  • Tuomilehto J, Karvonen M, Pitkäniemi E, et al. Record-high incidence of type 1 (insulin-dependent) diabetes mellitus in Finnish children. Diabetologia. 1999;42:655–660.
  • Enander R, Gundevall C, Stromgren A, et al. Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. Pediatr Diabetes. 2012;13:545–551.
  • Rewers MJ, Pillay K, de Beaufort C, et al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes. 2014;15(Suppl. 20):102–114.
  • Cameron FJ, de Beaufort C, Anstoot H-J, et al. Lessons from the Hvidoere International study group on childhood diabetes: be dogmatic about outcome and flexible in approach. Pediatr Diabetes. 2013;14:473–480.
  • Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290:2159–2167.
  • Donaghue K, Fung A, Hing S, et al. The effect of prepubertal diabetes duration on diabetes. Microvascular complications in early and late adolescence. Diabetes Care. 1997;20:77–80.
  • Dovc K, Telic S, Lusa L, et al. Improved metabolic control in pediatric patients with type 1 diabetes: a nationwide prospective 12-year time trends analysis. Diabetes Technol Ther. 2014;16(1):33–40.
  • Fullerton B, Jeitler K, Seitz M, et al. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014 [cited 2017 Mar 12];2:CD009122. DOI:10.1002/14651858.CD009122.pub2
  • Report of the ADA/EAS/IDF working group of the HbA1c assay, London, UK. Diabetologia. 2014;47:R53–R54.
  • Rhea JM, Molinaro R. Pathology consultation on hba1c methods and interferences. Am J Clin Pathol. 2014;141:5–16.
  • Rhea JM, Koch D, Ritchie J, et al. Unintended reporting of misleading HbA1c values when using assays incapable of detecting hemoglobin variants. Arch Pathol Lab Med. 2013;137:1788–1791.
  • Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013;33:393–400.
  • Witsch M, Kosteria I, Kordonouri O, et al. Possibilities and challenges of a large international benchmarking in pediatric diabetology. The SWEET experience. J Pediatr Diabetes. 2016;17(Suppl. 23):7–15.
  • Alexander V, Blair A, Blair M, et al. Factors influencing glycemic control in young people with type 1 diabetes in Scotland. A population-based study (DIABAUD2). Diabetes Care. 2001;24:239–244.
  • Ngwiri T, Fred Were F, Predieri B, et al. Glycemic control in Kenyan children and adolescents with type 1 diabetes mellitus. Int J Endocrinol. 2015 [cited 2017 Mar 12];2015:761759. DOI:10.1155/2015/761759
  • McKnight JA, Wild SH, Lamb MJE, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabetic Med. 2015;32:1036–1050.
  • Hanberger L, Akesson K, Samuelsson U. Glycated haemoglobin variations in paediatric type 1 diabetes: the impact of season, gender and age. Acta Paediatrica. 2014;103(4):398–403.
  • O'hagan M, Harvey JN, Brecon Group. Glycemic control in children with type 1 diabetes in Wales. Influence of the pediatric diabetes specialist nurse. Diabetes Care. 2010;33:1724–1726.
  • Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36:2035–2037.
  • Samualsson U, Hanberger L, Pundzuite-Lycka A, et al. Yearly report. SWEDAIDKIDS. National quality register for children and adolescents with diabetes. Register Center Vastra Gotaland; 2013. Available from:https://swediabkids.ndr.nu/
  • Cameron FJ, Amin R, de Beaufort C, et al. ISPAD clinical practice consensus guidelines – 2014: diabetes in adolescence. Pediatr Diabetes. 2014;15(Suppl. 20):245–256.
  • Battelino T, Longet I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55(12):3155–3162.
  • Berghaeuser MA, Kapellen T, Heidtmann B, et al. Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes. 2008;9:590–595.
  • Szypowska A, Schwandt A, Svensson J, et al. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry. J Pediatr Diabetes. 2016;17(Suppl. 23):38–45.
  • Sherr JL, Herrmann JM, Campbell F, et al. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries. Diabetologia. 2016;59(1):87–91.
  • Phillip M, Danne T, Battelino T, et al. Use of insulin pump therapy in the pediatric age-group. Consensus statement from the ESPE, the LWPES and ISPAD, endorsed by ADA and EASD. Diabetes Care. 2007;30:1653–1662.
  • Litton J, Rice A, Friedman N, et al. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatrics. 2002;141:490–495.
  • Thabit H, Tauschmann M, Allen JM. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med. 2015;373:2129–2140.